Dr. Kröger is a research scientist at the Centre d’excellence sur le vieillissement de Québec (CEVQ) du CIUSSSCN and an adjunct professor at the Faculté de pharmacie de l’Université Laval and at the Department of Family Medicine of McGill University. A pharmacist and (pharmaco-) epidemiologist by training, Dr Kröger uses data from epidemiological cohort studies or from administrative data banks for her research. She also performs systematic, scoping or mixed methods knowledge syntheses. For over 10 years, she has been studying risk factors for dementia (Interview with the Australian Broadcasting Corporation, Seafood: mercury and dementia, http://www.abc.net.au/radionational/programs/(healthreport/seafood,-mercury,-and-dementia./7149328, ABC).
Dr. Kröger’s current research program focuses on the medication treatment of seniors affected by dementia. It aims at improving medication use and, more specifically, deprescribing medications of questionable benefit (http://pourvivreensante.com/est-ce-que-je-prends-trop-de-medicaments/). Since 2013, she has been leading intervention and evaluation studies in long-term care facilities to assess whether interdisciplinary knowledge exchange interventions, together with critical medication reviews based on validated criteria, are successful in deprescribing medications of questionable benefit and to decrease residents’ medication load.(« OptimaMed » and « PEPS » studies http://www.ciusss-capitalenationale.gouv.qc.ca/sites/default/files/medication_demence_severe_oct2015.pdf).
Furthermore, Dr. Kröger is an affiliated researcher at the Institut national de santé publique du Québec (INSPQ) where she collaborates in the surveillance of dementia and related diseases in the Quebec population (https://www.inspq.qc.ca/es/node/4223).She is also a member of the Scientific Council of the Institut national d’excellence en santé et en services sociaux (INESSS) and a scientist member of the Ethics Research Board of the CIUSSSCN.
1050, chemin Sainte-Foy
L2-30
Québec, Québec
Canada G1S 4L8
Latest news
Data not available
- Poisblaud, LiseEmployeeHôpital Saint-Sacrementlise.poisblaud@crchudequebec.ulaval.ca
1050 Chemin Sainte-Foy
Québec, QC
Canada G1S 4L8 - Savard, CatherineEmployeeHôpital Saint-Sacrementcatherine.savard@crchudequebec.ulaval.ca
1050, chemin Sainte-Foy
L2-11
Québec, QC
Canada G1S 4L8
A nursing mentoring programme on non-pharmacological interventions against BPSD: Effectiveness and use of antipsychotics-A retrospective, before-after study.
Journal ArticleNurs Open, 2021.
Abstract | Links: 
Discontinuation of bisphosphonates in seniors: a systematic review on health outcomes.
Journal ArticleArch Osteoporos, 16 (1), 2021.
Abstract | Links:
Cannabis against chronic musculoskeletal pain: a scoping review on users and their perceptions.
Journal ArticleJ Cannabis Res, 3 (1), 2021.
Abstract | Links:
Medical cannabis for chronic pain.
Journal ArticleBMJ, 374 , 2021.
| Links: 
A New Care Model Reduces Polypharmacy and Potentially Inappropriate Medications in Long-Term Care.
Journal ArticleJ Am Med Dir Assoc, 22 (1), 2021.
Abstract | Links:
Cognitive Impairment and Length of Stay in Acute Care Hospitals: A Scoping Review of the Literature.
Journal ArticleCan J Aging, 40 (3), 2021.
Abstract | Links:
User-centered and theory-based design of a professional training program on shared decision-making with older adults living with neurocognitive disorders: a mixed-methods study.
Journal ArticleBMC Med Inform Decis Mak, 21 (1), 2021.
Abstract | Links:
Professional training on shared decision making with older adults living with neurocognitive disorders: a mixed-methods implementation study.
Journal ArticleBMC Med Inform Decis Mak, 20 (1), 2020.
Abstract | Links:
Is Benzodiazepine Use Associated With the Risk of Dementia and Cognitive Impairment-Not Dementia in Older Persons? The Canadian Study of Health and Aging.
Journal ArticleAnn Pharmacother, 54 (3), 2020.
Abstract | Links:
Polypharmacy Definitions for Multimorbid Older Adults Need Stronger Foundations to Guide Research, Clinical Practice and Public Health.
Journal ArticlePharmacy (Basel), 7 (3), 2019.
Abstract | Links:
Active projects
- Phase Two of the Canadian Consortium on Neurodegeneration in Aging, from 2019-04-01 to 2024-03-31
- Projet de recherche sur les modèles novateurs de milieu de vie des aînés atteints de problèmes cognitifs : similitudes, différences, forces et défis, from 2019-04-01 to 2023-03-31
- Projet GPS: Évaluation de l'impact de la réorganisation du travail en Groupe de médecine de famille (GMF) sur la Pharmacothérapie et le Soutien à l'autonomie des personnes âgées ayant un trouble neuro-cognitif majeur, from 2019-04-01 to 2022-06-30
- Validation du questionnaire d’Auto-repérage pour Vieillir En Santé (AVES) pour permettre aux personnes aînées d’évaluer elles-mêmes leurs risques de perte d'autonomie, from 2021-03-01 to 2023-03-31
- Vers des milieux de travail et des milieux de vie en CHSLD contributifs d'une meilleure santé durable des travailleurs, des résidents et de leurs proches, from 2021-04-30 to 2022-04-30
- Vivre et Vieillir à Québec, from 2021-10-01 to 2022-09-30
Recently finished projects
- Adoption de comportements préventifs chez les ainés vulnérables en situation d'épidémie /pandémie : vers une participation sociale sécuritaire (sans sortir de la maison) et une réduction des risques accrues , from 2020-04-01 to 2021-03-31
- Development and initial validation of measures of cancer pain under- and overtreatment, from 2020-04-01 to 2021-03-31
- Le cannabis médical contre la douleur musculosquelettique chronique : des outils d'aide à la décision pour les patients et les cliniciens , from 2020-04-01 to 2021-03-31
- Le cannabis médical contre les douleurs musculo-squelettiques chroniques : une étude de l'usage parmi des personnes âgées de 60 ans et plus au Québec et au Canada, from 2018-04-01 to 2020-03-31
- Le cannabis médical contre les douleurs musculosquelettiques chroniques: une étude aux méthodes mixtes sur les déterminants de l'usage parmi des patients et des médecins canadiens, from 2019-03-01 to 2020-02-29